Skip to main content
Log in

New Chemotherapeutic Agents for Influenza Virus Infections

Summary and Table

  • Section 1: Anti-Influenza Chemotherapy
  • Adis Profile Summary
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Prevention and control of influenza: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep 1999 Apr 30; 48 (RR-4): 1–28

  2. Advisory Committee on Immunization Practices. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1998 May 10; 47 Suppl. RR-6: 1–26

    Google Scholar 

  3. McBean AM, Babish JD, Warren JL. The impact and cost of influenza in the elderly. Arch Intern Med 1993; 153: 210–1

    Article  Google Scholar 

  4. Dunn CJ, Goa KL. Zanamivir: a review of its use in influenza. Drugs 1999. In press

    Google Scholar 

  5. Bardsley-Elliot A, Noble S. Oseltamivir. Drugs 1999. In press

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wilde, M.I., Paterson, R. New Chemotherapeutic Agents for Influenza Virus Infections. Drugs R&D 2, 165–169 (1999). https://doi.org/10.2165/00126839-199902030-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199902030-00002

Keywords

Navigation